 SAN FRANCISCO, Oct. 29, 2020 GLOBE NEWSWIRE -- Eidos Therapeutics, Inc. Eidos Nasdaq:EIDX, today reported its financial results for the third quarter ended September 30, 2020 and provided an update on the companys operations. 